In 2023, the trade exchange (includes international purchases and sales) of Vitamin B12 and Derivatives Thereof Used Primarily as Vitamins was US$21.6M.
In 2023, the states with the most international sales in Vitamin B12 and Derivatives Thereof Used Primarily as Vitamins were Ciudad de México (US$31).
The states with the most international purchases in 2023 were Ciudad de México (US$13.2M), Estado de México (US$2.41M), Jalisco (US$1.7M), and Querétaro (US$315k).
In 2023, the main commercial destinations of Vitamin B12 and Derivatives Thereof Used Primarily as Vitamins were Cuba (US$23), Costa Rica (US$5), and Italy (US$3).
The main commercial origins of Vitamin B12 and Derivatives Thereof Used Primarily as Vitamins in 2023 were France (US$12.9M), China (US$4.23M), Switzerland (US$225k), Germany (US$161k), and United States (US$23.2k).
In the global context, the main exporting countries of Vitamin B12 and Derivatives Thereof Used Primarily as Vitamins in 2022 were China (US$174M), France (US$49.7M), and Netherlands (US$20.6M). In the same year, the main importing countries of Vitamin B12 and Derivatives Thereof Used Primarily as Vitamins were United States (US$76.3M), India (US$35.8M), and Japan (US$17.1M).